ANIK
Anika Therapeutics Inc
Price:  
17.65 
USD
Volume:  
67,239.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika Relative Valuation

-1292.7%
Upside

As of 2025-02-14, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (210.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.65 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -1292.7%.

The range of the Relative Valuation is (194.51) - (259.08) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.9x - 42.4x 29.2x
Forward P/E multiples 29.2x - 38.9x 34.0x
Fair Price (194.51) - (259.08) (210.52)
Upside -1202.0% - -1567.9% -1292.7%
17.65 USD
Stock Price
(210.52) USD
Fair Price

Anika Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -2.67
2025-02-06 -2.67
2025-02-05 -2.70
2025-02-04 -2.68
2025-02-03 -2.60
2025-01-31 -2.56
2025-01-30 -2.60
2025-01-29 -2.54
2025-01-28 -2.51
2025-01-27 -2.51
2025-01-24 -2.45
2025-01-23 -2.46
2025-01-22 -2.44
2025-01-21 -2.48
2025-01-17 -2.41
2025-01-16 -2.43
2025-01-15 -2.41
2025-01-14 -2.34
2025-01-13 -2.39
2025-01-10 -2.34
2025-01-08 -2.39
2025-01-07 -2.36
2025-01-06 -2.39
2025-01-03 -2.43
2025-01-02 -2.44
2024-12-31 -2.47
2024-12-30 -2.44
2024-12-27 -2.44
2024-12-26 -2.50
2024-12-24 -2.45
2024-12-23 -2.44
2024-12-20 -2.45
2024-12-19 -2.45
2024-12-18 -2.41
2024-12-17 -2.50
2024-12-16 -2.54
2024-12-13 -2.58
2024-12-12 -2.60
2024-12-11 -2.68
2024-12-10 -2.68
2024-12-09 -2.59
2024-12-06 -2.62
2024-12-05 -2.63
2024-12-04 -2.64
2024-12-03 -2.61
2024-12-02 -2.64
2024-11-29 -2.66
2024-11-27 -2.66
2024-11-26 -2.66
2024-11-25 -2.58